Advertisement
Advertisement

LNSR

LNSR logo

LENSAR Inc

9.56
USD
+0.36
+3.91%
Jan 24, 12:36 UTC -5
Open

LENSAR Inc Profile

About

LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.

Info & Links

CEO

Nicholas T. Curtis

Headquarters

2800 Discovery Drive
Orlando, FL 32826, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

82

Employees

130

LENSAR Inc Statistics

Valuation Measures

Market Capitalization2

110.99M

Enterprise Value

100.55M

Enterprise Value/EBITDA(ttm)

-11.45

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.98

Price to Book(mrq)

4.25

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

49.06%

Operating Margin(ttm)

-28.00%

Profit Margin(ttm)

-33.87%

Return on Equity(ttm)

-49.02%

Return on Invested Capital(ttm)

-63.37%

Return on Assets(ttm)

-21.12%

Income Statement

Revenue(ttm)

48.87M

Revenue Per Share(ttm)

4.21

Gross Profit(ttm)

23.89M

EBITDA(ttm)3

-8.78M

Net Income Available to Common(ttm)

-16.63M

Diluted EPS(ttm)

-1.46

Share Statistics

Beta (5Y Monthly)

0.63

52-Week Change

283.94%

S&P 500 52-Week Change

25.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

11.61M

Dividend Yield

0.00%

Float4

7.14M

% Held by Insiders

38.52%

% Held by Institutions

40.15%

Balance Sheet

Total Cash(mrq)

18.08M

Total Cash Per Share(mrq)

1.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.37%

Quick Ratio(mrq)

2.10%

Book Value Per Share(mrq)

1.96

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.51

Free Cash Flow(ytd)

-6.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement